2026-09-06 08:46 UTC
@tao@mathstodon.xyz Most of this is over my head and I don’t know what ansatz means(!), but is a reasonable TLDR/summary that PA (probabilistic automation) in pure maths can be considered analogous to the “negative result problem” in pharma (and academic publishing broadly) where neg results are discarded or not reported even though they may have value in respect of other problems, or at least “here’s why method 1027 doesn’t work”?
In the case, because nobody actually does any thinking about to understand *why* it doesn’t work.
This would be very ironic considering a touted use-case for PA is to trawl pharma datasets for compounds that were passed over as unsuitable for the target application but which might have another use that we not identified at the time.
Of course, pharma research is more about concrete results, whereas pure math is more about broader thinking, and failed approaches can profoundly inform seemingly-unrelated fields.
Replies (1)
-
@dat@social.g33ky.de 2026-09-08 16:53
it's funny how for me (german with only rudimentary math skills) I think to know what "ansatz" means and the literal translation "approach" even seems to fit the context, but it's probably overloaded with some math-specific meaning of that I don't know shit?